Novel method for generating structure-based pharmacophores using energetic analysis.

Area of Science:

• Computational Chemistry
• Drug Discovery
• Bioinformatics

Background:

• Structure-based pharmacophore development is crucial for efficient virtual screening.
• Existing methods for pharmacophore generation and screening have limitations in accuracy and diversity.

Purpose of the Study:

• To introduce a novel method for developing energetically optimized, structure-based pharmacophores.
• To enhance rapid in silico screening for drug discovery.
• To compare the new method against existing approaches for enrichment and diversity of active compounds.

Main Methods:

• Combining pharmacophore perception and database screening with protein-ligand energetic terms (Glide XP scoring).
• Deriving energy-optimized pharmacophore hypotheses from 30 crystal structures.
• Assessing enrichment of active compounds in a screened database.
• Comparing the novel method with contact-based pharmacophores, Glide SP docking, and 2D ligand fingerprint similarity.

Main Results:

• The novel method demonstrated superior enrichment compared to the other three approaches.
• It yielded greater diversity of active molecules than contact-based pharmacophores and 2D ligand similarity.
• Glide SP docking achieved the highest number of cases with significant enrichment (28/30) and good diversity.

Conclusions:

• The developed method effectively combines structure-based energy terms with ligand-based pharmacophore search speed.
• This hybrid approach leverages the strengths of both strategies for high enrichment and diverse active molecule identification.
• The method offers a significant advancement in rapid in silico screening for drug discovery.